The national government covers treatments that the provinces reject, mainly Buenos Aires, led by Axel Kicillof
"I also remind you that always and in every case, the National Government addresses the cases that the provinces reject. Requests are initiated in the provincial Ministries of Health, and when you reject in writing to cover a treatment—even in oncology and high-cost cases—the Nation intervenes," Lugones emphasized in his response to the Buenos Aires official.
In practice, the national government has become the last guarantor of access to critical treatments, taking on responsibilities that some provincial governments, with Kicillof's Buenos Aires at the forefront, are not willing to assume.
Meanwhile, Javier Milei's government allocates billions in resources to guarantee the health of those who need it most, while unfounded accusations are launched from Kirchnerism that, rather than reflecting genuine concern for patients, seem intended to generate confusion and fear among the public, all for political purposes.
While the Kirchnerist opposition attempts to promote a narrative of neglect in healthcare, official data show a very different reality. Since 2024, Javier Milei's government has invested more than $270,000 million in oncology medications for patients without coverage, a large portion of which were treatments rejected by the provinces themselves, especially Buenos Aires, governed by Axel Kicillof.
This figure comes from the official response of the Minister of Health, Mario Lugones, who strongly refuted the accusations made by Facundo Lanza, a Kirchnerist official from the Buenos Aires Ministry of Security, who had claimed without evidence that "all three branches of government are letting patients die."
In response to these serious accusations, Lugones detailed that in 2024 alone, the Ministry of Health allocated $115,000 million to oncology treatments through the National Directorate of Direct and Compensatory Assistance (DINADIC) and the Special Drug Bank. So far in 2025, more than $70,000 million have already been executed, and another $85,000 million are projected for the second half of the year, bringing the total to more than $270,000 million.
